Europe Digital Health Ecosystem 2023 Mid Year Report
- $1.38B of venture funding was deployed in H1 2023 to ventures founded in Europe, a decline of 53% from H1 2022.
- Europe has moved into the top spot across the globe for Clinical Evidence, with 22% of all ventures attaining a significant level of Clinical Evidence, indicating that the ventures’ Digital Health solutions can improve the outcomes of the patient population that is being addressed
- After taking second place to France in 2022, the United Kingdom is back to leading venture funding in Europe in H1 2023, capturing 32% of venture funding value.
- … and much more
The “Europe Digital Health Innovation Ecosystem Report on H1 2023 Key Trends” report includes data on the following companies: Baseimmune, Doctorly, Alba Health, Gleamer, Phlo, Roche, AstraZeneca, Novartis, Pfizer, Cyted, Nye Health, SOPHiA GENETICS, BenevolentAI, Alex Therapeutics, Volta Medical, Distalmotion, Alentis Therapeutics, Patient21, Peppy, Caristo Diagnostics, Memodio, Perspectum Diagnostics, EBAMed, Skin + Me, Deeplink Medical, Dxcover, Nelly, InFlow, Haystack Oncology, Diamond Whites, Maela, UgenTec, Blackford Analytics, Bayer AG, Nouveal, Jefferson Health, Ada Health, RetinAI Medical, AIG, MediQuo, Gaia, Chugai Pharmaceutical
HealthTech Alpha, a Galen Growth proprietary solution, powers this report!
